The role of quantitative hepatitis B surface antigen revisited

M Cornberg, VWS Wong, S Locarnini, M Brunetto… - Journal of …, 2017 - Elsevier
In the past 10 years, there has been a lot of enthusiasm surrounding the use of serum
hepatitis B surface antigen (HBsAg) quantification to predict disease activity and monitor …

Clinical utility of quantitative HBsAg in natural history and nucleos (t) ide analogue treatment of chronic hepatitis B: new trick of old dog

TC Tseng, JH Kao - Journal of gastroenterology, 2013 - Springer
Using commercial quantitative assays, quantitative hepatitis B surface antigen (qHBsAg) has
improved our understanding and management of chronic hepatitis B (CHB). The HBsAg …

[HTML][HTML] Western blot: technique, theory, and trouble shooting

T Mahmood, PC Yang - North American journal of medical …, 2012 - ncbi.nlm.nih.gov
Western blotting is an important technique used in cell and molecular biology. By using a
western blot, researchers are able to identify specific proteins from a complex mixture of …

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

YF Liaw, JH Kao, T Piratvisuth, HLY Chan… - Hepatology …, 2012 - Springer
Large volume of new data on the natural history and treatment of chronic hepatitis B virus
(HBV) infection have become available since 2008. These include further studies in …

Safety and efficacy of nucleic acid polymers in monotherapy and combined with immunotherapy in treatment-naive Bangladeshi patients with HBeAg+ chronic …

M Al-Mahtab, M Bazinet, A Vaillant - PloS one, 2016 - journals.plos.org
Previous in vivo studies have suggested that nucleic acid polymers (NAPs) may reduce
circulating levels of HBsAg in the blood by blocking its release from infected hepatocytes …

Reduction of hepatitis B surface antigen and covalently closed circular DNA by nucleos (t) ide analogues of different potency

DKH Wong, WK Seto, J Fung, P Ip, FY Huang… - Clinical …, 2013 - Elsevier
Background & Aims Few studies have investigated the effects of different nucleos (t) ide
analogues against hepatitis B virus (HBV) on levels of covalently closed circular DNA …

Use of HBsAg quantification in the natural history and treatment of chronic hepatitis B

LY Mak, WK Seto, J Fung, MF Yuen - Hepatology International, 2020 - Springer
In patients with chronic hepatitis B (CHB) infection, it is important to monitor the natural
history, assess treatment response, and predict the risk of liver-related complications …

[HTML][HTML] Taiwan consensus statement on the management of chronic hepatitis B

RN Chien, JH Kao, CY Peng, CH Chen, CJ Liu… - Journal of the Formosan …, 2019 - Elsevier
The experts of Taiwan Association for the Study of Liver (TASL) have actively participated
and led the guidelines on hepatitis B virus (HBV) management by Asian Pacific Association …

[PDF][PDF] Reduction of hepatitis B surface antigen levels and hepatitis B surface antigen seroclearance in chronic hepatitis B patients receiving 10 years of nucleoside …

WK Seto, DKH Wong, J Fung, FY Huang, CL Lai… - …, 2013 - Wiley Online Library
The profile and clinical significance of serum hepatitis B surface antigen (HBsAg) levels
during long‐term nucleoside analogue (NA) therapy in chronic hepatitis B (CHB) is …

Quantification of HBsAg in nucleos (t) ide-naive patients treated for chronic hepatitis B with entecavir with or without tenofovir in the BE-LOW study

F Zoulim, G Carosi, S Greenbloom, W Mazur… - Journal of …, 2015 - Elsevier
Background & Aims Serum hepatitis B surface antigen (HBsAg) levels may predict treatment
response in chronic hepatitis B (CHB). We examined the association between changes in …